Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
55,76 USD | -0,56 % | +12,35 % | +421,25 % |
Resumen de negocios
Número de empleados: 64
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Immunotherapies
100,0
%
| 9 | 100,0 % | 8 | 100,0 % | -6,14 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 8 | 100,0 % | -6,14 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Campbell
CEO | Chief Executive Officer | 65 | 01/06/17 |
Tighe Reardon
DFI | Director of Finance/CFO | 48 | 01/06/17 |
Jenna Daly
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/05/18 | |
Charles Winter
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Andy Meyer
IRC | Investor Relations Contact | 40 | 01/03/21 |
James Pennington
LAW | General Counsel | - | - |
Human Resources Officer | - | 23/09/22 | |
Byron Robinson
PRN | Corporate Officer/Principal | 59 | 01/03/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Vickie Capps
BRD | Director/Board Member | 62 | 18/03/21 |
Jay Lichter
CHM | Chairman | 62 | 01/06/17 |
Director/Board Member | 68 | 07/09/21 | |
David Campbell
CEO | Chief Executive Officer | 65 | 01/06/17 |
Alana McNulty
BRD | Director/Board Member | 61 | 07/09/21 |
Sheila Gujrathi
BRD | Director/Board Member | 53 | 18/03/21 |
Winston Kung
BRD | Director/Board Member | 48 | 22/09/22 |
Jake Simson
BRD | Director/Board Member | 38 | 01/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 51 670 379 | 44 543 167 ( 86,21 %) | 10 319 ( 0,0200 %) | 86,21 % |
Información de la empresa
Janux Therapeutics, Inc.
10955 Vista Sorrento Parkway Suite 200
92130, San Diego
+
http://www.januxrx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+421,25 % | 2896,52 M | |
+0,29 % | 42,86 mil M | |
+11,94 % | 42,74 mil M | |
+44,30 % | 41,36 mil M | |
-6,20 % | 27,68 mil M | |
+5,54 % | 25,15 mil M | |
-23,95 % | 18,63 mil M | |
+27,44 % | 12,37 mil M | |
-3,85 % | 11,92 mil M | |
+7,29 % | 11,21 mil M |
- Bolsa de valores
- Acciones
- Acción JANX
- Empresa Janux Therapeutics, Inc.